Article
Updated Insights on EGFR Signaling Pathways in Glioma
8 Jan 2021
Abstract excerpt
Nowadays, due to recent advances in molecular biology, the pathogenesis of glioblastoma is better understood. For the newly diagnosed, the current standard of care is represented by resection followed by radiotherapy and temozolomide administration, but because median overall survival remains poor, new diagnosis and treatment strategies are needed. Due to the quick progression, even with aggressive multimodal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
